Publications by authors named "Laurent Gauthier"

Claim this Profile
G
Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.
Sophie Guia, Aurore Fenis, Camille Baudesson De Chanville, Justine Galluso, Hakim Medjouel, Laurent Gauthier

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities.
Kamlesh Bisht, Aimee Merino, Rob Igarashi, Laurent Gauthier, Marielle Chiron

Exp Hematol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma.
Olivier Demaria, Guillaume Habif, Marie Vetizou, Laurent Gauthier, Romain Remark

Sci Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New immune cell engagers for cancer immunotherapy.
Aurore Fenis, Olivier Demaria, Laurent Gauthier, Eric Vivier, Emilie Narni-Mancinelli

Nat Rev Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Tumor accommodation: the importance of the niche in neurological tumors.
Roberta Azzarelli, Laurent R Gauthier, Jose R Pineda, Maria Angeles Marques-Torrejon

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Amandine Decroos, Morgane Cheminant, Julie Bruneau, Sylvain Carras, Vincent Parinet, Laurent Gauthier

Haematologica· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123.
Laurent Gauthier, Angela Virone-Oddos, Jochen Beninga, Benjamin Rossi, Céline Nicolazzi

Nat Biotechnol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XLF/Cernunnos loss impairs mouse brain development by altering symmetric proliferative divisions of neural progenitors.
Amandine Bery, Olivier Etienne, Laura Mouton, Sofiane Mokrani, Christine Granotier-Beckers, Laurent R Gauthier

Cell Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population genetic diversity and dynamics of the honey bee brood pathogen Melissococcus plutonius in a region with high prevalence.
Daniela Grossar, Edward Haynes, Giles E Budge, Melanie Parejo, Laurent Gauthier

J Invertebr Pathol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Olivier Demaria, Laurent Gauthier, Marie Vetizou, Audrey Blanchard Alvarez, Constance Vagne

Cell Rep Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New polynomial regression formula to improve second-eye refractive outcomes in sequential bilateral cataract surgery.
Édouard Klein, François Malecaze, Victor Bart, Anouk Barnoud, Pierre Lévy, Laurent Gauthier

J Cataract Refract Surg· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.
Natalia Colomar-Carando, Laurent Gauthier, Pietro Merli, Fabrizio Loiacono, Paolo Canevali

Cancer Immunol Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.
Mathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel, Florence Lhospice, Delphine Bregeon, Laurent Gauthier

Open Res Eur· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increase in lamin B1 promotes telomere instability by disrupting the shelterin complex in human cells.
Gaëlle Pennarun, Julien Picotto, Laure Etourneaud, Anna-Rita Redavid, Anaïs Certain, Laurent R Gauthier

Nucleic Acids Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments.
Olivier Demaria, Laurent Gauthier, Guilhaume Debroas, Eric Vivier

Eur J Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putative determinants of virulence in , the bacterial agent causing European foulbrood in honey bees.
Daniela Grossar, Verena Kilchenmann, Eva Forsgren, Jean-Daniel Charrière, Laurent Gauthier

Virulence· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HIF1α/JMY pathway promotes glioblastoma stem-like cell invasiveness after irradiation.
Laurent R Gauthier, Mahasen Saati, Hayet Bensalah-Pigeon, Karim Ben M'Barek, Oscar Gitton-Quent

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles as a platform to study cell-surface membrane proteins.
Vincent Delauzun, Beatrice Amigues, Anais Gaubert, Philippe Leone, Magali Grange, Laurent Gauthier

Methods· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting Cytotoxic Antibodies against Cancer.
Laurent Gauthier, Eric Vivier

Cell· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Natural killer cells: promising targets in cancer therapy].
Stéphanie Cornen, Pascale André, Laurent Gauthier, Yannis Morel, Éric Vivier

Med Sci (Paris)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.
Carole Beck, José Manuel Rodriguez-Vargas, Christian Boehler, Isabelle Robert, Vincent Heyer, Laurent R Gauthier

Cell Death Differ· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
Laurent Gauthier, Ariane Morel, Nadia Anceriz, Benjamin Rossi, Audrey Blanchard-Alvarez

Cell· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
Ivan Perrot, Henri-Alexandre Michaud, Marc Giraudon-Paoli, Séverine Augier, Aurélie Docquier, Laurent Gauthier

Cell Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition.
Dalal Bakhos-Douaihy, Chantal Desmaze, Maya Jeitany, Laurent R Gauthier, Denis Biard

Oncotarget· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon-Caillet, Julie Lopez, Laurent Gauthier

Cell· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis